logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9498437 B1

PDFFull Text
Date of Patent:
Nov. 22, 2016

Filed:

Dec. 22, 2005

Inhalable formulations for treating pulmonary hypertension and methods of using same

Applicant:

Imtiaz Chaudry, Napa, CA (US);

Inventor:

Imtiaz Chaudry, Napa, CA (US);

Assignee:

Mylan Specialty L.P., Basking Ridge, NJ (US);

Attorney:
Primary Examiner:

Jane C Oswecki

Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/00 (2006.01); A61K 31/401 (2006.01); A61K 31/404 (2006.01); A61K 31/472 (2006.01); A61K 31/55 (2006.01); A61K 31/5575 (2006.01); A61K 31/5585 (2006.01); A61K 31/675 (2006.01); A61K 38/55 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0078 (2013.01); A61K 31/00 (2013.01); A61K 31/401 (2013.01); A61K 31/404 (2013.01); A61K 31/472 (2013.01); A61K 31/55 (2013.01); A61K 31/5575 (2013.01); A61K 31/5585 (2013.01); A61K 31/675 (2013.01); A61K 38/556 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention is directed to an inhalable formulation for the treatment of pulmonary hypertension in a mammal (e.g., humans), wherein the formulation comprises at least one hypertension reducing agent, including but not limited to an angiotensin converting enzyme inhibitor, angiotensin receptor blocker, beta-blocker, calcium-channel blocker or vasodilator, or any combination thereof. The formulations of the present invention may be a solution or suspension, and preferably are suitable for administration via nebulization. The present invention is also directed to a method and kit for treating a mammal suffering from pulmonary hypertension.

Find Patent Forward Citations

Loading…